TFF PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
TFF PHARMACEUTICALS, INC. reported Share-based Payment Arrangement, Expense of $567.67 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $567.67K, a 25.92% decline year-over-year.
- TFF PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $608.35K, a 26.32% decline year-over-year.
- TFF PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $766.32K, a 19.80% decline year-over-year.
- TFF PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $825.72K.
- TFF PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2019 was $590.04K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 11 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $567.67K 10-Q · filed 2024-11-20 | $1.18M derived: sum of 2 quarters · filed 2024-11-20 | $1.80M 10-Q · filed 2024-11-20 | |||
| 2024-06-30 | $608.35K 10-Q · filed 2024-08-14 | $1.24M 10-Q · filed 2024-08-14 | ||||
| 2023-09-30 | $766.32K 10-Q · filed 2024-11-20 | $1.59M derived: sum of 2 quarters · filed 2024-11-20 | $2.34M 10-Q · filed 2024-11-20 | |||
| 2023-06-30 | $825.72K 10-Q · filed 2024-08-14 | $1.58M 10-Q · filed 2024-08-14 | ||||
| 2022-09-30 | $955.56K 10-Q · filed 2023-11-14 | $3.33M 10-Q · filed 2023-11-14 | ||||
| 2020-09-30 | $546.12K 10-Q · filed 2020-11-05 | $841.48K derived: sum of 2 quarters · filed 2020-11-05 | $1.27M derived: sum of 3 quarters · filed 2020-11-05 | |||
| 2020-06-30 | $295.36K 10-Q · filed 2020-11-05 | $721.20K derived: sum of 2 quarters · filed 2020-11-05 | ||||
| 2020-03-31 | $425.84K 10-Q · filed 2020-11-05 | |||||
| 2019-12-31 | $590.04K 10-K · filed 2020-03-27 | |||||
| 2019-09-30 | -$229.02K 10-Q · filed 2020-11-05 | $257.38K derived: sum of 2 quarters · filed 2020-11-05 | $378.61K derived: sum of 3 quarters · filed 2020-11-05 | |||
| 2019-06-30 | $486.40K 10-Q · filed 2020-11-05 | $486.40K 10-Q · filed 2019-12-09 | $607.62K derived: sum of 2 quarters · filed 2020-11-05 | |||
| 2019-03-31 | $121.23K 10-Q · filed 2020-11-05 | |||||
| 2018-12-31 | $150.99K 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | $62.11K 10-Q · filed 2019-12-09 | $1.24M derived: sum of 2 quarters · filed 2019-12-09 | ||||
| 2018-06-30 | $1.17M 10-Q · filed 2019-12-09 |